Stacey B Weston

Title: **Innovative Contributions of Stacey B Weston in Hemostasis Research**

Introduction

Stacey B Weston is an accomplished inventor based in Dracut, Massachusetts, whose innovative contributions to the field of biomedicine have led to two significant patents. With a focus on advancing medical treatments, her work primarily involves methods for purifying Factor Xa variant proteins, which are essential in the process of hemostasis.

Latest Patents

Stacey's most recent patents include the development of compositions comprising recombinant variants of the human clotting Factor Xa. These compositions encapsulate a diverse range of isoforms and incorporate various post-translational modifications of FXa. They hold great promise for treating individuals in need of support for hemostasis, thus representing a crucial advancement in therapeutic options.

Career Highlights

Stacey B Weston is a key member of the Pfizer Corporation, where she applies her expertise in biochemistry and pharmacology to research and develop new medical treatments. Her work is vital for the progression of hemostatic therapies that can significantly improve patient outcomes during surgical procedures and in managing clotting disorders.

Collaborations

Throughout her career, Stacey has collaborated with notable colleagues such as Keith A Johnson and Jason C Rouse. These partnerships have enriched her research endeavors, allowing for impactful advancements in the understanding and application of FXa variants in clinical settings.

Conclusion

As an inventor, Stacey B Weston exemplifies the spirit of innovation in the medical field. Her patents focusing on Factor Xa variant proteins pave the way for new treatments that enhance hemostatic processes and improve the quality of care for patients, solidifying her role as a significant contributor to biomedical research and development.